Researchers develop under-the-skin implant to treat Type 1 diabetes

Scientists have developed a new implantable device that has the potential to change the way Type 1 diabetics receive insulin. The thread-like implant, or SHEATH (Subcutaneous Host-Enabled Alginate THread), is installed in a two-step process that ultimately leads to the deployment of “islet devices,” which are derived from the cells that produce insulin in our bodies naturally.